NLS Pharmaceutics receives initial tranche of share sale to BVF
Zurich/San Francisco - NLS Pharmaceutics has sold shares to the biotech investor BVF Partners and secured gross proceeds of 10 million dollars in the process. A second, much larger tranche is anticipated to take place towards the end of 2024. As a result, NLS is now in a position to finance its business operations and research activities up to 2025.
Study confirms feasibility of environmentally friendly fertilizers
Zurich - Nitrogen fertilizers can be produced in a carbon-neutral manner under certain conditions and in certain locations. Given that this would benefit the climate, reduce natural gas imports and secure food supplies, a study has now examined which production methods would feasibly make sense.
Designwerk building megawatt charging station for trucks
Winterthur - At Designwerk, one of the world’s first megawatt-class charging stations is currently under development. With a rapid charging time of just 45 minutes, a Swiss consortium is seeking to make electric trucks suitable for long-distance routes and relieve the burden on power networks.
IRsweep launches compact laser module on the market
Stäfa - IRsweep is now offering a cost-effective, compact laser module. The Laser Module C is suitable for all existing IRsweep spectrometers. With the most commonly used symmetrical beam configuration, it covers the majority of applications.
Synhelion raises funds for industrial solar fuel plant
Lugano/Kloten - Synhelion has raised 22 million Swiss francs in a funding round, in which it gained Swiss International Air Lines as an investor. The funds will go into an industrial plant for solar fuel production.
The LOOP Zurich supports new research projects in personalized medicine
Zurich - The research center The LOOP Zurich is supporting two new data-sensitive projects in the area of personalized medicine. The first deals with recurring urinary tract infections, while the other seeks to help obese patients with a particular predisposition to secondary diseases.
ETH and armasuisse join forces for security robotics
Zurich/Thun - The Swiss Federal Institute of Technology Zurich (ETH) and armasuisse S+T are launching a security robotics program. Together, they will develop robots for unarmed missions by rescue and security forces.
AliperTherapeutics wins Boldbrain Challenge
Lugano - The biotech company AliperTherapeutics has proven victorious in the Boldbrain Challenge 2022. Second place in the incubator went to another life science startup: Healiva. Zario and Effetto Venturi also won awards, with fifth place and the public award going to Revozona.
Trading with tokenized investment products successful in Switzerland
Zurich/Geneva - Key players in the Swiss financial industry have successfully developed and tested a novel settlement mechanism for tokenized investment products in Swiss francs. It will enable the industry to increase efficiency and simplify cross-border settlement.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space